The goal of solid state research for different stages of pharmaceutical development is to guide researchers in finding an optimal API phase and formulation for the particular stage of development.  Our model is a fit for purpose solid state research approach that:

     •     Minimizes resources

     •     Eliminates wasted time and effort

     •     Is guided by a right first time philosophy

     •     Provides a full understanding of solid state properties for both API and formulation

     •     Understands the impact of form and formulation on processing and performance

We have broken the pharmaceutical development process into three main categories to highlight the type of solid state research necessary at each development stage.  Each stage requires a certain level of due diligence with respect to solid state research.

          Preclinical development

          Early clinical development

          Late clinical development/marketed product